Jasmin Tiro to Papillomavirus Infections
This is a "connection" page, showing publications Jasmin Tiro has written about Papillomavirus Infections.
Connection Strength
8.306
-
Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study. Cancer Prev Res (Phila). 2023 03 01; 16(3):127-132.
Score: 0.717
-
Human Papillomavirus Vaccination Before and During the COVID-19 Pandemic. JAMA Netw Open. 2022 09 01; 5(9):e2234000.
Score: 0.693
-
Mechanisms of self-persuasion intervention for HPV vaccination: Testing memory and autonomous motivation. Health Psychol. 2021 Dec; 40(12):887-896.
Score: 0.637
-
Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result. J Womens Health (Larchmt). 2019 03; 28(3):384-392.
Score: 0.534
-
Translating self-persuasion into an adolescent HPV vaccine promotion intervention for parents attending safety-net clinics. Patient Educ Couns. 2017 04; 100(4):736-741.
Score: 0.464
-
Characterizing safety-net providers' HPV vaccine recommendations to undecided parents: A pilot study. Patient Educ Couns. 2016 09; 99(9):1452-60.
Score: 0.451
-
Does language moderate the influence of information scanning and seeking on HPV knowledge and vaccine awareness and initiation among Hispanics? Ethn Dis. 2013; 23(1):95-102.
Score: 0.355
-
Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. J Womens Health (Larchmt). 2012 Jun; 21(6):656-65.
Score: 0.336
-
Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer. 2008 Nov 15; 113(10 Suppl):3013-30.
Score: 0.266
-
What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):288-94.
Score: 0.235
-
Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial. JAMA. 2023 11 28; 330(20):1971-1981.
Score: 0.189
-
Timing of Colposcopy and Risk of Cervical Cancer. Obstet Gynecol. 2023 11 01; 142(5):1125-1134.
Score: 0.185
-
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
Score: 0.179
-
Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systems. JNCI Cancer Spectr. 2023 01 03; 7(1).
Score: 0.177
-
Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 Nov 01; 5(11):e2244343.
Score: 0.175
-
Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial. Contemp Clin Trials. 2022 11; 122:106960.
Score: 0.175
-
Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 02; 12(3):3705-3717.
Score: 0.174
-
Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics. Am J Prev Med. 2022 04; 62(4):538-547.
Score: 0.166
-
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871.
Score: 0.164
-
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Front Immunol. 2021; 12:624230.
Score: 0.157
-
Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Cancer. 2021 03 15; 127(6):850-864.
Score: 0.154
-
Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review. JAMA Otolaryngol Head Neck Surg. 2020 07 01; 146(7):656-664.
Score: 0.149
-
Authors' response: Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populations. Prev Med. 2020 10; 139:106081.
Score: 0.147
-
Cost-effectiveness studies of HPV self-sampling: A systematic review. Prev Med. 2020 03; 132:105953.
Score: 0.144
-
Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits. J Med Screen. 2020 09; 27(3):146-156.
Score: 0.143
-
Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial. JAMA Netw Open. 2019 11 01; 2(11):e1914729.
Score: 0.142
-
Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019 03 15; 144(6):1460-1473.
Score: 0.134
-
Advancing Human Papillomavirus Vaccine Delivery: 12 Priority Research Gaps. Acad Pediatr. 2018 03; 18(2S):S14-S16.
Score: 0.127
-
Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system. Contemp Clin Trials. 2018 01; 64:77-87.
Score: 0.124
-
Modification and validation of the Treatment Self Regulation Questionnaire to assess parental motivation for HPV vaccination of adolescents. Vaccine. 2016 09 22; 34(41):4985-4990.
Score: 0.114
-
Human papillomavirus vaccine coverage among females aged 11 to 17 in Texas counties: an application of multilevel, small area estimation. Womens Health Issues. 2013 Mar-Apr; 23(2):e131-41.
Score: 0.090
-
Effects of socioeconomic status and health care access on low levels of human papillomavirus vaccination among Spanish-speaking Hispanics in California. Am J Public Health. 2013 Feb; 103(2):270-2.
Score: 0.088
-
Understanding how mothers of adolescent girls obtain information about the human papillomavirus vaccine: associations between mothers' health beliefs, information seeking, and vaccination intentions in an ethnically diverse sample. J Health Psychol. 2013 Jul; 18(7):926-38.
Score: 0.087
-
Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California. Vaccine. 2012 Apr 19; 30(19):3003-8.
Score: 0.083
-
Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012 Mar 16; 30(13):2368-75.
Score: 0.082
-
One in four California adolescent girls have had human papillomavirus vaccination. Policy Brief UCLA Cent Health Policy Res. 2009 Feb; (PB2009-3):1-6.
Score: 0.068